Inspire Medical Systems, Inc.INSPEarnings & Financial Report
NYSE
INSP Q4 2025 Key Financial Metrics
Revenue
$269.1M
Gross Profit
$233.0M
Operating Profit
$46.1M
Net Profit
$136.1M
Gross Margin
86.6%
Operating Margin
17.1%
Net Margin
50.6%
YoY Growth
12.2%
EPS
$4.57
Financial Flow
Inspire Medical Systems, Inc. Q4 2025 Financial Summary
Inspire Medical Systems, Inc. reported revenue of $269.1M for Q4 2025, with a net profit of $136.1M (50.6% margin). Cost of goods sold was $36.1M, operating expenses totaled $186.9M.
Key Financial Metrics
| Total Revenue | $269.1M |
|---|---|
| Net Profit | $136.1M |
| Gross Margin | 86.6% |
| Operating Margin | 17.1% |
| Report Period | Q4 2025 |
Inspire Medical Systems, Inc. Annual Revenue by Year
Inspire Medical Systems, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $912.0M).
| Year | Annual Revenue |
|---|---|
| 2025 | $912.0M |
| 2024 | $802.8M |
| 2023 | $624.8M |
| 2022 | $407.9M |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.0M | $195.9M | $203.2M | $239.7M | $201.3M | $217.1M | $224.5M | $269.1M |
| YoY Growth | 28.2% | 29.6% | 32.5% | 24.5% | 22.7% | 10.8% | 10.5% | 12.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $685.8M | $728.4M | $796.2M | $808.4M | $730.8M | $802.2M | $807.7M | $907.3M |
| Liabilities | $96.8M | $90.3M | $99.6M | $118.7M | $95.1M | $124.4M | $141.3M | $126.2M |
| Equity | $589.0M | $638.1M | $696.6M | $689.7M | $635.7M | $677.8M | $666.5M | $781.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $8.9M | $-78000 | $52.3M | $69.2M | $-6.7M | $2.7M | $68.5M | $52.5M |